📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. (2022)

First Author: RECOVERY Collaborative Group

Attributed to: Randomised trials in cardiovascular and metabolic disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(22)01109-6

PubMed Identifier: 35908569

Publication URI: http://europepmc.org/abstract/MED/35908569

Type: Journal Article/Review

Volume: 400

Parent Publication: Lancet (London, England)

Issue: 10349

ISSN: 0140-6736